Innate Pharma's Series B Round

Innate Pharma raised a round of funding on July 17, 2002.

Innate Pharma is a biopharmaceutical company developing first-in-class drugs targeting innate immunity. The Company is currently developing three product platforms (gamma delta T cells, NK cells and T…

Articles about Innate Pharma's Series B Round: